thank you for your
subscription
We hope you love it!
Please let us know about any feedback or suggestions you might have at info@drughunter.com
Highlights
-
- Molecules of the Month
May
A fat-tissue-targeting clinical candidate, a first-in-class Ph. III molecule that inhibits its target by covalently modifying the target’s substrate,…
1 min read
-
- Article
2021 First-in-Class Large Molecule Drug Approvals (Pt. III)
This deep dive into 2021’s first-in-class large molecule drug approvals is the third in a series of focus articles…21 mins read
-
- Article
May 2022 Molecules of the Month Runners Up
Readers have been asking for more molecules, so this month, we’re starting a new feature that will highlight a…6 mins read
-
- Article
Shaken by An Unexpected Patient Connection
with Julien Lefranc We asked one of our reviewers, Julien Lefranc, about what inspires and excites him about drug…4 mins read
-
- Reference
What Makes a Drug Best-in-Class?
How a Follow-on Drug Can Create Value After a First-in-Class Drug Novel drugs can make a big impact in…3 mins read
-
- Reference
An Introduction to Fragment-Based Drug Discovery (FBDD)
In this minireview, Dr. Romyr Dominique introduces three key concepts in fragment-based drug discovery and shares his favorite articles…8 mins read